CircTLK1 : A novel regulator involved in VSMC phenotypic switching and the developmental process of atherosclerosis
The FASEB Journal · 2024
DOI: 10.1096/fj.202301873rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Feng Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Atherosclerosis, MicroRNAs, Myocytes, Smooth Muscle, RNA, Circular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Key Research and Development Program of Hubei Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Phenotypic switching of vascular smooth muscle cells (VSMCs) is essential for atherosclerosis development. Circular RNA (circRNA) is a specific non‐coding RNA that is produced as a closed‐loop structure in mammals, and its specific expression pattern is closely related to its cell type and tissue. To clarify the roles of circTLK1 in VSMC phenotypic switching, we performed qRT‐PCR, immunoblotting, and immunostaining. qRT‐PCR revealed that circTLK1 was upregulated in both mouse models of atherosclerosis in vivo and PDGF (platelet‐derived growth factor)–BB‐induced VSMCs in vitro. Furthermore, the overexpression of circTLK1 promoted PDGF‐BB‐induced VSMC phenotypic switching. Conversely, experiments performed in vivo demonstrate that the knockdown of SMC‐specific circTLK1 led to a reduction in the development of atherosclerosis. The relationship between circTLK1 and miR‐513a‐3p and Krüppel‐like factor 4 (KLF4) was detected by RNA immunoprecipitation (RIP), luciferase reporter assay, RNA pull‐down, and RNA fluorescence in situ hybridization (RNA FISH). Mechanistically, circTLK1 acted as a sponge for miR‐513a‐3p, leading to the upregulation of KLF4, a key transcription factor for phenotypic switching. Targeting the circTLK1/miR‐513a‐3p/KLF4 axis may provide a potential therapeutic strategy for atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Feng Zhang, Xuying Xiang, Cheng Wen, Xiaoqing Guo, Lei Nie, Jiaojiao Chen, Yuanpeng Xia, Bo Hu, Ling Mao
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Key Research and Development Program of Hubei Province
- National Natural Science Foundation of China
Zitieren
APA
Zhang, F., Xiang, X., Wen, C., Guo, X., Nie, L., Chen, J., Xia, Y., Hu, B., & Mao, L. (2024). CircTLK1 : A novel regulator involved in VSMC phenotypic switching and the developmental process of atherosclerosis. The FASEB Journal. https://doi.org/10.1096/fj.202301873rr
Vancouver
Zhang F, Xiang X, Wen C, Guo X, Nie L, Chen J, et al. CircTLK1 : A novel regulator involved in VSMC phenotypic switching and the developmental process of atherosclerosis. The FASEB Journal. 2024. doi:10.1096/fj.202301873rr
BibTeX
@article{Zhang2024,
author = {Zhang, Feng and Xiang, Xuying and Wen, Cheng and Guo, Xiaoqing and Nie, Lei and Chen, Jiaojiao and Xia, Yuanpeng and Hu, Bo and Mao, Ling},
title = {CircTLK1 : A novel regulator involved in VSMC phenotypic switching and the developmental process of atherosclerosis},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202301873rr}
}
EUVIMED